Pharmaids Pharmaceuticals Ltd Quarterly Result

Pharmaids Pharmaceuticals Ltd Quarterly Result

Image

Pharmaids Pharmaceuticals Ltd

NSE: PHARMAIDSPHARMA

Net Profit - Last Quarter

₹ -1.08 Cr.

Last updated on: Aug 01, 2026

Pharmaids Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Pharmaids Pharmaceuticals Ltd for the Mar '26 is ₹ 7.28 crore as compare to the Dec '25 revenue of ₹ 5.51 crore.
  • This represent the growth of 32.12% The ebitda of Pharmaids Pharmaceuticals Ltd for the Mar '26 is ₹ -0.33 crore as compare to the Dec '25 ebitda of ₹ -2.83 crore.
  • This represent the decline of -88.34% The net profit of Pharmaids Pharmaceuticals Ltd for the Mar '26 is ₹ -1.08 crore as compare to the Dec '25 net profit of ₹ -2.65 crore.
  • This represent the decline of -59.25%.

Pharmaids Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Pharmaids Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Pharmaids Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
31 Jul 202631
30 Jul 202630.78
29 Jul 202630.3
28 Jul 202630.02
27 Jul 202630.49
24 Jul 202630.59
23 Jul 202630.54
22 Jul 202630.97
21 Jul 202631.03
20 Jul 202630.99

Historical Revenue of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Pharmaids Pharmaceuticals Ltd News Hub

Pharmaids Pharmaceuticals to convene board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 August

Read more

21 Aug 24

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.68 crore in the June 2024 quarter

Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.68 crore in the quarter ended June 2024 as ag

Read more

14 Aug 24

Pharmaids Pharmaceuticals schedules board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August

Read more

07 Aug 24

Pharmaids Pharmaceuticals AGM scheduled

Pharmaids Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company will b

Read more

03 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Pharmaids Pharmaceuticals Ltd

  • Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana were suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc.
  • The technical team used quality proven chemical compounds and standard processing methods maintaining proper hygiene standards.The Company is engaged in the business of contract research and manufacturing services. Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019.
  • Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019. The Company acquired 25.5% stake as 1st tranche in Anugraha Chemicals, a Partnership Firm, registered under Karnataka Partnership Rules, 1954 on February 1, 2023.

FAQs for Quarterly Results of Pharmaids Pharmaceuticals Ltd

What key financial metrics are included in Pharmaids Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Pharmaids Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Pharmaids Pharmaceuticals Ltd announce its quarterly results?

Pharmaids Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Pharmaids Pharmaceuticals Ltd's quarterly performance impact its stock price?

Pharmaids Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Pharmaids Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Pharmaids Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Pharmaids Pharmaceuticals Ltd's quarterly results?

Yes, Pharmaids Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions